These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. Moore SW; Appfelstaedt J; Zaahl MG J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543 [TBL] [Abstract][Full Text] [Related]
3. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease. Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157 [TBL] [Abstract][Full Text] [Related]
4. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation. Moore SW; Zaahl M J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359 [TBL] [Abstract][Full Text] [Related]
5. [Thyroid carcinomas and Hirschsprung's disease--10-year experience with molecular genetic testing of the RET proto-oncogene]. Bendlová B; Dvoráková S; Václavíková E; Sýkorová V; Vlcek P; Skába R Vnitr Lek; 2006 Oct; 52(10):926-34. PubMed ID: 17063805 [TBL] [Abstract][Full Text] [Related]
6. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related]
7. RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest. Vaclavikova E; Dvorakova S; Sykorova V; Bilek R; Dvorakova K; Vlcek P; Skaba R; Zelinka T; Bendlova B Endocrine; 2009 Dec; 36(3):419-24. PubMed ID: 19826964 [TBL] [Abstract][Full Text] [Related]
8. The association between Hirschsprung's disease and multiple endocrine neoplasia type 2a: a systematic review. Coyle D; Friedmacher F; Puri P Pediatr Surg Int; 2014 Aug; 30(8):751-6. PubMed ID: 24972642 [TBL] [Abstract][Full Text] [Related]
9. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds. Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480 [TBL] [Abstract][Full Text] [Related]
10. The Hirschsprung's-multiple endocrine neoplasia connection. Moore SW; Zaahl M Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):63-7. PubMed ID: 22584708 [TBL] [Abstract][Full Text] [Related]
11. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192 [TBL] [Abstract][Full Text] [Related]
12. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2. Toledo SP; dos Santos MA; Toledo Rde A; Lourenço DM Clinics (Sao Paulo); 2006 Feb; 61(1):59-70. PubMed ID: 16532227 [TBL] [Abstract][Full Text] [Related]
13. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation. Frank-Raue K; Raue F Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387 [TBL] [Abstract][Full Text] [Related]
14. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report. Menon MM; Simha MR Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of MEN 2a in familial Hirschsprung's disease: a new indication for genetic testing of the RET proto-oncogene. Decker RA; Peacock ML J Pediatr Surg; 1998 Feb; 33(2):207-14. PubMed ID: 9498388 [TBL] [Abstract][Full Text] [Related]
16. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Krampitz GW; Norton JA Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901 [TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. Wells SA; Pacini F; Robinson BG; Santoro M J Clin Endocrinol Metab; 2013 Aug; 98(8):3149-64. PubMed ID: 23744408 [TBL] [Abstract][Full Text] [Related]
18. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. Pasini B; Rossi R; Ambrosio MR; Zatelli MC; Gullo M; Gobbo M; Collini P; Aiello A; Pansini G; Trasforini G; degli Uberti EC Surgery; 2002 Apr; 131(4):373-81. PubMed ID: 11935126 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. Klein I; Esik O; Homolya V; Szeri F; Váradi A J Endocrinol; 2001 Sep; 170(3):661-6. PubMed ID: 11524247 [TBL] [Abstract][Full Text] [Related]
20. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer. Lodish MB; Stratakis CA Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]